SLC29A1 and lung carcinoma: Moreover, a recent study by Achiwa et al (2004) demonstrated that increased hENT1 expression was a determinant of gemcitabine sensitivity, while the decreased dCK expression was associated with acquired resistance to gemcitabine in lung cancer cells (Achiwa et al, 2004).